Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in Nucl Med Commun

Retrieve available abstracts of 204 articles:
HTML format
Text format



Single Articles


    January 2017
  1. YEUNG CS, Musaddaq B, Hare S, Wagner T, et al
    18F-FDG-PET/CT study after lung biopsy in suspected lung cancer patients: time is of the essence.
    Nucl Med Commun. 2017;38:99-100.
    PubMed     Text format    


  2. DUBREUIL J, Tordo J, Rubello D, Giammarile F, et al
    Diffusion-weighted MRI and 18F-FDG-PET/CT imaging: competition or synergy as diagnostic methods to manage sarcoma of the uterus? A systematic review of the literature.
    Nucl Med Commun. 2017;38:84-90.
    PubMed     Text format     Abstract available


    November 2016
  3. KABASAKAL L, Demirci E, Nematyazar J, Akyel R, et al
    The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  4. WANG R, Xu B, Guo Z, Chen T, et al
    Suite PET/CT neuroimaging for the diagnosis of Parkinson's disease: statistical parametric mapping analysis.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  5. MA H, Shen G, Liu B, Yang Y, et al
    Diagnostic performance of 18F-FDG PET or PET/CT in restaging renal cell carcinoma: a systematic review and meta-analysis.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  6. DUBREUIL J, Giammarile F, Rousset P, Rubello D, et al
    18F-FDG-PET/CT of peritoneal tumors: a pictorial essay.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


    October 2016
  7. QIU L, Tu G, Li J, Chen Y, et al
    The role of 18F-FDG PET and PET/CT in the evaluation of primary cutaneous lymphoma.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  8. SONMEZOGLU K, Vatankulu B, Elverdi T, Akyel R, et al
    The role of 68Ga-DOTA-TATE PET/CT scanning in the evaluation of patients with multiple myeloma: preliminary results.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  9. SAH BR, Stolzmann P, Delso G, Wollenweber SD, et al
    Clinical evaluation of a block sequential regularized expectation maximization reconstruction algorithm in 18F-FDG PET/CT studies.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  10. RUILONG Z, Daohai X, Li G, Xiaohong W, et al
    Diagnostic value of 18F-FDG-PET/CT for the evaluation of solitary pulmonary nodules: a systematic review and meta-analysis.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  11. RASTOGI A, Bhattacharya A, Prakash M, Sharma S, et al
    Utility of PET/CT with fluorine-18-fluorodeoxyglucose-labeled autologous leukocytes for diagnosing diabetic foot osteomyelitis in patients with Charcot's neuroarthropathy.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  12. FALLAHI B, Beiki D, Salehi Y, Emami-Ardekani A, et al
    Reverse perfusion pattern in myocardial perfusion imaging using technetium-99m-sestamibi in patients with intermediate risk for coronary artery disease in relation to the time of acquisition and intensity of visceral uptake as artifactual causes.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  13. ALANAZI SF, Alzimami KS, Ghannam MM, Aljammaz IJ, et al
    Quantitative imaging characteristics of zirconium-89 on Gemini Time-Of-Flight PET/CT.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  14. HASSAN A, Riaz S, Zafar W
    Fluorine-18 fluorodeoxyglucose avid thyroid incidentalomas on PET/CT scan in cancer patients: how sinister are they?
    Nucl Med Commun. 2016;37:1069-73.
    PubMed     Text format     Abstract available


    September 2016
  15. KALSY N, Vinjamuri S
    Should we stop offering indium-111 octreotide scans in favour of gallium-68 PET-CT scans in the UK?
    Nucl Med Commun. 2016.
    PubMed     Text format    


  16. BARRIO M, Czernin J, Yeh MW, Palma Diaz MF, et al
    The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  17. KLUIJFHOUT WP, Vorselaars WM, van den Berk SA, Vriens MR, et al
    Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  18. KAEWPUT C, Vinjamuri S
    Comparison of renal uptake of 68Ga-DOTANOC PET/CT and estimated glomerular filtration rate before and after peptide receptor radionuclide therapy in patients with metastatic neuroendocrine tumours.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  19. HE S, Tang G, Hu K, Wang S, et al
    Preclinical evaluation of 5-([11C]-methyloxy)-L-tryptophan as a potential PET molecular imaging probe.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  20. ONAL C, Torun N, Guler OC, Yildirim BA, et al
    Prognostic value of metabolic response measured by 18F-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  21. HALL M, Beadsmoore C, Allen S, Abbotts N, et al
    Coding in nuclear medicine, from examination to tariff: an iterative process.
    Nucl Med Commun. 2016.
    PubMed     Text format    


  22. VOGEL WV, Bloemers MC, van der Heide UA, Beets-Tan RG, et al
    Accuracy of PET/MRI coregistration of cervical lesions.
    Nucl Med Commun. 2016;37:997-8.
    PubMed     Text format    


    August 2016
  23. ABIKHZER G, Srour S, Fried G, Drumea K, et al
    Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  24. EVANGELISTA L, Zattoni F, Karnes RJ, Novara G, et al
    Radiolabeled choline PET/CT before salvage lymphadenectomy dissection: a systematic review and meta-analysis.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  25. DADPOUR B, Dabbagh Kakhki VR, Afshari R, Dorri-Giv M, et al
    Myocardial perfusion and left ventricular function indices assessed by gated myocardial perfusion SPECT in methamphetamine abusers.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  26. ARMSTRONG IS, Hoffmann SA
    Activity concentration measurements using a conjugate gradient (Siemens xSPECT) reconstruction algorithm in SPECT/CT.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  27. ADAMS HJ, Kwee TC
    Does interim 18F-FDG-PET response-adapted therapy really benefit advanced-stage Hodgkin lymphoma patients?
    Nucl Med Commun. 2016.
    PubMed     Text format    


  28. MINAMIMOTO R
    Response to 'Commentary to "Evaluation of a new motion correction algorithm in PET/CT: combining the entire acquired PET data to create a single three-dimensional motion-corrected PET/CT image."'.
    Nucl Med Commun. 2016;37:888.
    PubMed     Text format    


  29. HAVARIYOUN G
    Commentary to 'Evaluation of a new motion correction algorithm in PET/CT: combining the entire acquired PET data to create a single three-dimensional motion-corrected PET/CT image'.
    Nucl Med Commun. 2016;37:888.
    PubMed     Text format    


  30. HWANG JP, Lim I, Byun BH, Kim BI, et al
    Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


    July 2016
  31. VATANKULU B, Isik G, Kocael P, Kuyumcu S, et al
    Do 18F-FDG PET/CT findings have a relationship with histopathological and immunohistochemical factors of breast cancer in men?
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  32. UCAK SEMIRGIN S, Basoglu T, Atmaca Saglik B, Sahin M, et al
    Diagnostic value of additional 18F-FDG PET/CT imaging using a vaginal catheter in patients with paravaginal malignant lesions.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  33. LIU H, Chen Y, Wu S, Song F, et al
    Molecular imaging using PET and SPECT for identification of breast cancer subtypes.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  34. XIAO Y, Wang L, Jiang X, She W, et al
    Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  35. CLEARY JO, Yeung J, McMeekin H, Wilhelm T, et al
    The significance of incidental brain uptake on 68Ga-DOTATATE PET-CT in neuroendocrine tumour patients.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  36. STANGIERSKI A, Kaznowski J, Wolinski K, Jodlowska E, et al
    The usefulness of fluorine-18 fluorodeoxyglucose PET in the detection of recurrence in patients with differentiated thyroid cancer with elevated thyroglobulin and negative radioiodine whole-body scan.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


    June 2016
  37. JIMENEZ-BONILLA JF, Banzo I, De Arcocha-Torres M, Quirce R, et al
    Diagnostic role of 11C-Pittsburgh compound B retention patterns and glucose metabolism by fluorine-18-fluorodeoxyglucose PET/CT in amnestic and nonamnestic mild cognitive impairment patients.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  38. TEAGLE AR, Gilbert DC, Jones JR, Burkill GJ, et al
    Negative 18F-FDG-PET-CT may exclude residual or recurrent disease in anal cancer.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  39. DEMIRCI E, Sahin OE, Ocak M, Akovali B, et al
    Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  40. JOHANSSON J, Alakurtti K, Joutsa J, Tohka J, et al
    Comparison of manual and automatic techniques for substriatal segmentation in 11C-raclopride high-resolution PET studies.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  41. DE OLIVEIRA COSTA R, Hallack Neto A, Siqueira S, Lage LA, et al
    Interim fluorine-18 fluorodeoxyglucose PET-computed tomography and cell of origin by immunohistochemistry predicts progression-free and overall survival in diffuse large B-cell lymphoma patients in the rituximab era.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  42. MA Y, Shao X, Shao X, Wang X, et al
    High metabolic characteristics of uterine fibroids in 18F-FDG PET/CT imaging and the underlying mechanisms.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  43. LEE H, Paeng JC, Hong SH, Yoo HJ, et al
    Appropriate margin thresholds for isocontour metabolic volumetry of fluorine-18 fluorodeoxyglucose PET in sarcoma: a hybrid PET/MRI study.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  44. PAL S, Sen S, Das D, Basu S, et al
    Examining a hypothetical quantitative model for better approximation of culprit coronary artery and site of stenosis on 99mTc-sestamibi gated myocardial perfusion SPECT.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  45. KLEN R, Noponen T, Koikkalainen J, Lotjonen J, et al
    Evaluation of motion-correction methods for dual-gated cardiac positron emission tomography/computed tomography imaging.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  46. TAGHIPOUR M, Sheikhbahaei S, Trahan TJ, Subramaniam RM, et al
    Value of fourth and subsequent post-therapy follow-up 18F-FDG PET/CT scans in patients with breast cancer.
    Nucl Med Commun. 2016;37:602-8.
    PubMed     Text format     Abstract available


  47. GORLA AK, Sood A, Mittal BR
    Role of choline PET/CT in evaluation of primary and secondary hyperparathyroidism.
    Nucl Med Commun. 2016;37:672.
    PubMed     Text format    


  48. BASU S, Ostwal V
    Observation on enhanced avidity on somatostatin receptor targeted 68Ga-DOTATATE PET-CT following therapy with everolimus and capecitabine-temozolamide: is redifferentiation akin phenomenon a reality in neuroendocrine tumors?
    Nucl Med Commun. 2016;37:669-71.
    PubMed     Text format    


    May 2016
  49. PASCUAL TN
    Examining Quality Management Audits in Nuclear Medicine Practice as a lifelong learning process: opportunities and challenges to the nuclear medicine professional and beyond.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  50. TRIPATHI M, Agarwal KK, Mukherjee A, Thukral P, et al
    99mTc-DMSA planar imaging versus dual-detector SPECT for the detection of renal cortical scars in patients with CKD-3.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  51. LE Y, Chen Y, Zhou F, Liu G, et al
    Comparative diagnostic value of 18F-fluoride PET-CT versus MRI for skull-base bone invasion in nasopharyngeal carcinoma.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  52. JIN S, Boktor RR, Kc Man K, Pitman AG, et al
    Normal range of osteoblastic activity in total hip arthroplasties on single-photon emission computed tomography bone scintigraphy.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  53. YUAN H, Tong DK, Vardhanabhuti V, Law SY, et al
    PET/CT in the evaluation of treatment response to neoadjuvant chemoradiotherapy and prognostication in patients with locally advanced esophageal squamous cell carcinoma.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  54. QUARTUCCIO N, Caobelli F, Di Mauro F, Cammaroto G, et al
    Non-18F-FDG PET/CT in the management of patients affected by HNC: state-of-the-art.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  55. KWON HW, Lee HY, Hwang YH, Park HC, et al
    Diagnostic performance of 18F-FDG-labeled white blood cell PET/CT for cyst infection in patients with autosomal dominant polycystic kidney disease: a prospective study.
    Nucl Med Commun. 2016;37:493-498.
    PubMed     Text format     Abstract available


    April 2016
  56. SOLIMAN K, Alenezi A, Alqahtani S
    Variability in the amount of fluorine-18 fluorodeoxyglucose excreted in urine measured from oncology patients during PET/computed tomography imaging.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  57. GUO HH, Moradi F, Iagaru A
    Clinical significance of extraskeletal computed tomography findings on 18F-NaF PET/CT performed for osseous metastatic disease evaluation.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  58. ABDULREZZAK U, Kurt YK, Kula M, Tutus A, et al
    Combined imaging with 68Ga-DOTA-TATE and 18F-FDG PET/CT on the basis of volumetric parameters in neuroendocrine tumors.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  59. PETER J, Houshmand S, Werner TJ, Rubello D, et al
    Novel assessment of global metabolism by 18F-FDG-PET for localizing affected lobe in temporal lobe epilepsy.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  60. BEN-HAIM S, Garkaby J, Primashvili N, Goshen E, et al
    Metabolic assessment of Merkel cell carcinoma: the role of 18F-FDG PET/CT.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  61. JODAL L, Hansen SB, Jensen SB
    Impact of contamination with long-lived radionuclides on PET kinetics modelling in multitracer studies.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  62. DAVIDSON T, Goshen E, Eshed I, Goldstein J, et al
    Incidental detection of elastofibroma dorsi on PET-CT: initial findings and changes in tumor size and standardized uptake value on serial scans.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  63. VAN DEN BERG NS, Engelen T, Brouwer OR, Matheron HM, et al
    A pilot study of SPECT/CT-based mixed-reality navigation towards the sentinel node in patients with melanoma or Merkel cell carcinoma of a lower extremity.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  64. HONG JH, Jung US, Min KJ, Lee JK, et al
    Prognostic value of total lesion glycolysis measured by 18F-FDG PET/CT in patients with locally advanced cervical cancer.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  65. FENDLER WP, Bluemel C, Rubello D, Herrmann K, et al
    Have we overcome choline PET/CT for early detection of prostate cancer recurrence?
    Nucl Med Commun. 2016.
    PubMed     Text format    


    March 2016
  66. TAGHIPOUR M, Marcus C, Jones S, Sarangi R, et al
    The value of fourth and subsequent post-treatment 18F-FDG PET/CT scans in the management of patients with non-Hodgkin's lymphoma.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  67. WANG H, Zhang Y, Yu W, Zhao X, et al
    Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1alpha evaluated by 18F-FDG and 18F-FMISO PET/CT.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  68. DEMIR O, Kose N, Ozkan E, Unluturk U, et al
    Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  69. VIGNE J, De Mil R, Peyronnet D, Hecquard C, et al
    Fractionated elution using the TEKCIS technetium-99m generator.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  70. CALABRIA F, Schillaci O
    The biodistribution of the radiolabeled kinds of choline in male patients, assessed by PET/CT.
    Nucl Med Commun. 2016;37:329-30.
    PubMed     Text format    


  71. SI C, Mok GS, Chen L, Tsui BM, et al
    Design and evaluation of an adaptive multipinhole collimator for high-performance clinical and preclinical imaging.
    Nucl Med Commun. 2016;37:313-21.
    PubMed     Text format     Abstract available


  72. KURISU S, Iwasaki T, Ikenaga H, Watanabe N, et al
    Association of mitral annular velocity with myocardial ischemia assessed by single-photon emission computed tomography in patients with suspected coronary artery disease and preserved ejection fraction.
    Nucl Med Commun. 2016;37:278-82.
    PubMed     Text format     Abstract available


    February 2016
  73. VAN VLIET KE, van Eck-Smit BL, de Jong VM, Goslings JC, et al
    Physiological uptake values of 18F-FDG in long bones of the lower extremity on PET/CT imaging.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  74. STAVROU PZ, Papachristou M, Persakis E, Kouvelis K, et al
    Residual activities of 99mTc-labelled radiopharmaceuticals in routine nuclear medicine practice.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  75. ADAMS HJ, Kwee TC
    18F-FDG-PET is not a useful tool for end-of-treatment response evaluation in peripheral T-cell lymphomas.
    Nucl Med Commun. 2016;37:217.
    PubMed     Text format    


  76. IM HJ, Paeng JC, Cheon GJ, Kim EE, et al
    Feasibility of simultaneous 18F-FDG PET/MRI for the quantitative volumetric and metabolic measurements of abdominal fat tissues using fat segmentation.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  77. JHA AK, Purandare N, Shah SA, Agrawal A, et al
    Is there a correlation between planar scintigraphy after 99mTc-MAA and 90Y administration?
    Nucl Med Commun. 2016;37:107-9.
    PubMed     Text format    


  78. MEINTJES M, Sathekge M, Makanjee CR, Dickson JC, et al
    Comparison of rubidium-82 myocardial blood flow quantification with coronary calcium score for evaluation of coronary artery stenosis.
    Nucl Med Commun. 2016;37:197-206.
    PubMed     Text format     Abstract available


  79. DEMIR Y, Surucu E, Sengoz T, Koc M, et al
    Liver metabolic activity changes over time with neoadjuvant therapy in locally advanced rectal cancer.
    Nucl Med Commun. 2016;37:116-21.
    PubMed     Text format     Abstract available


    January 2016
  80. AL-BULUSHI NK, Abouzied ME
    Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  81. LIU Y
    The role of 18F-FDG PET/CT in the follow-up of well-differentiated thyroid cancer with negative thyroglobulin but positive and/or elevated antithyroglobulin antibody.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  82. AL-MUQBEL KM, Yaghan RJ, Al-Omari MH, Rousan LA, et al
    Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET/CT in breast cancer patients.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  83. ZHANG S, Xin J, Sun H, Ma J, et al
    Accuracy of PET/MR image coregistration of cervical lesions.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  84. LIN KH, Lee RC, Liu RS, Chang CY, et al
    The prognostic value of tumor shadow disappearance rate on integrated PET/CT evaluation of solitary pulmonary nodules with low glucose metabolism.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  85. HOWARD BA, Roy Choudhury K, Oldan JD, Pagnanelli RA, et al
    Difference in appearance between prone and supine myocardial perfusion images obtained on a high-efficiency cadmium zinc telluride SPECT camera.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  86. TAWAKOL A, Abdelhafez YG, Osama A, Hamada E, et al
    Diagnostic performance of 18F-FDG PET/contrast-enhanced CT versus contrast-enhanced CT alone for post-treatment detection of ovarian malignancy.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  87. KOBAYASHI N, Inaba Y, Tezuka T, Ike H, et al
    Evaluation of local bone turnover in painful hip by 18F-fluoride positron emission tomography.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  88. CHAN HY, Tsoi A, Wong MP, Ho JC, et al
    Utility of 18F-FDG PET/CT in the assessment of lymphoepithelioma-like carcinoma.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  89. WANG C, Li P, Wu S, Lu J, et al
    The role of fluorine-18 fluorodeoxyglucose PET in prognosis evaluation for stem cell transplantation of lymphoma: a systematic review and meta-analysis.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  90. KAN H, Knol RJ, Lazarenko SV, Wondergem M, et al
    Occurrence of typical perfusion defects attributed to jailed or occluded side branch after ramus descendens anterior stenting in a patient cohort referred for 13NH3 myocardial PET/CT.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  91. BASU S, Ranade R, Thapa P
    177Lu-DOTATATE versus 177Lu-EDTMP versus cocktail/sequential therapy in bone-confined painful metastatic disease in medullary carcinoma of the thyroid and neuroendocrine tumour: can semiquantitative comparison of 68Ga-DOTATATE and 18F-fluoride PET-CT
    Nucl Med Commun. 2016;37:100-2.
    PubMed     Text format    


  92. ADAMS HJ, de Klerk JM, Fijnheer R, Heggelman BG, et al
    Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?
    Nucl Med Commun. 2016;37:23-9.
    PubMed     Text format     Abstract available


    December 2015
  93. BUCHERT R, Hutton C, Lange C, Hoppe P, et al
    Semiquantitative slab view display for visual evaluation of 123I-FP-CIT SPECT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  94. WILLEGAIGNON J, Pelissoni RA, Lima BC, Sapienza MT, et al
    Prediction of iodine-131 biokinetics and radiation doses from therapy on the basis of tracer studies: an important question for therapy planning in nuclear medicine.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  95. ZHU HJ, Hess S, Rubello D, Goris ML, et al
    The strong but nonspecific relationship between 18F-FDG uptake in the lower-extremity veins and venous thromboembolism.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  96. ARANDA-LARA L, Ferro-Flores G, Ramirez FM, Ocampo-Garcia B, et al
    Improved radiopharmaceutical based on 99mTc-Bombesin-folate for breast tumour imaging.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  97. WILLEGAIGNON J, Braga LF, Sapienza MT, Coura-Filho GB, et al
    Diagnostic reference level: an important tool for reducing radiation doses in adult and pediatric nuclear medicine procedures in Brazil.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  98. LIU C, Zhang Y, Zhang Y, Wang M, et al
    Diagnostic value of 18F-FDG PET/CT for cutaneous extranodal natural killer/T-cell lymphoma, nasal type.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  99. MARTINEZ T, Gallego Peinado M, Sanchez Catalicio J, Perez Angel F, et al
    Validation of the leukocyte labeling procedure with a new kit for the preparation of technetium-99m exametazime injection.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  100. SHEIKHBAHAEI S, Marcus C, Wray R, Rahmim A, et al
    Impact of point spread function reconstruction on quantitative 18F-FDG-PET/CT imaging parameters and inter-reader reproducibility in solid tumors.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  101. HOW KIT N, Dugue AE, Sevin E, Allouache N, et al
    Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  102. SHAO X, Shao X, Wang X, Wang Y, et al
    Applications of both time of flight and point spread function in brain PET image reconstruction.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  103. OSBORNE DR, Acuff S
    Whole-body dynamic imaging with continuous bed motion PET/CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


    November 2015
  104. FERNANDES RS, Silva JO, Lopes SC, Chondrogiannis S, et al
    Technetium-99m-labeled doxorubicin as an imaging probe for murine breast tumor (4T1 cell line) identification.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  105. FU Z, Liu M, Li Z, Fan Y, et al
    Is the bullhead sign on bone scintigraphy really common in the patient with SAPHO syndrome? A single-center study of a 16-year experience.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  106. BAHLER L, Holleman F, Booij J, Hoekstra JB, et al
    Interobserver and intraobserver variability for the assessment of brown adipose tissue activity on 18F-FDG PET-CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  107. AHMED R, Singh SP, Mittal BR, Rattan V, et al
    Role of fluorine-18 fluoride PET-CT scan in the assessment of unilateral condylar hyperplasia in faciomandibular asymmetry patients: a preliminary study.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  108. YI C, Yu D, Shi X, Zhang X, et al
    The combination of 13N-ammonia and 18F-FDG whole-body PET/CT on the same day for diagnosis of advanced prostate cancer.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  109. PETER J, Houshmand S, Werner TJ, Rubello D, et al
    Applications of global quantitative 18F-FDG-PET analysis in temporal lobe epilepsy.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  110. SHEIKHBAHAEI S, Wray R, Young B, Mena E, et al
    18F-FDG-PET/CT therapy assessment of locally advanced pancreatic adenocarcinoma: impact on management and utilization of quantitative parameters for patient survival prediction.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  111. SABOURY B, Parsons MA, Moghbel M, Rubello D, et al
    Quantification of aging effects upon global knee inflammation by 18F-FDG-PET.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  112. HO CY, Wu TH, Mok GS
    Interpolated average CT for PET attenuation correction in different lesion characteristics.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  113. YANG H, Zhuang H, Rubello D, Alavi A, et al
    Mild-to-moderate hyperglycemia will not decrease the sensitivity of 18F-FDG PET imaging in the detection of pedal osteomyelitis in diabetic patients.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  114. ROY S, Pathy S, Kumar R, Mohanti BK, et al
    Efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography as a predictor of response in locally advanced non-small-cell carcinoma of the lung.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  115. KALKANIS A, Kalkanis D, Drougas D, Vavougios GD, et al
    Correlation of spleen metabolism assessed by 18F-FDG PET with serum interleukin-2 receptor levels and other biomarkers in patients with untreated sarcoidosis.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  116. ABIKHZER G, Gourevich K, Kagna O, Israel O, et al
    Whole-body bone SPECT in breast cancer patients: the future bone scan protocol?
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


    October 2015
  117. FUSTER D, Torregrosa JV, Campos F, Giammarile F, et al
    Is there a role for PET/CT in the evaluation of primary and secondary hyperparathyroidism?
    Nucl Med Commun. 2015.
    PubMed     Text format    


  118. HAY PD, Smith J, O'Connor RA
    Evaluating the effect of a third-party implementation of resolution recovery on the quality of SPECT bone scan imaging using visual grading regression.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  119. MINAMIMOTO R, Mitsumoto T, Miyata Y, Sunaoka F, et al
    Evaluation of a new motion correction algorithm in PET/CT: combining the entire acquired PET data to create a single three-dimensional motion-corrected PET/CT image.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  120. HAN TT, Du M, Zhang X, Cao L, et al
    Quantitative assessment of early liver fibrosis in rats using 13N-NH3 H2O PET/CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  121. SOUFI M, Kamali-Asl A, Geramifar P, Abdoli M, et al
    Combined fuzzy logic and random walker algorithm for PET image tumor delineation.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  122. KIM H, Lee SJ, Davies-Venn C, Kim JS, et al
    64Cu-DOTA as a surrogate positron analog of Gd-DOTA for cardiac fibrosis detection with PET: pharmacokinetic study in a rat model of chronic MI.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  123. NAKAYA K, Otsuka H, Kondo K, Otani T, et al
    Tumor growth-inhibitory effect of an angiotensin-converting enzyme inhibitor (captopril) in a lung cancer xenograft model analyzed using 18F-FDG-PET/CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  124. ADAMS HJ, Kwee TC
    A negative 18F-FDG-PET scan can never exclude residual disease.
    Nucl Med Commun. 2015.
    PubMed     Text format    


  125. GABRIEL M, Rubello D
    18F-FDG PET-CT in soft tissue sarcomas: staging, restaging, and prognostic value?
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  126. KROSELJ M, Socan A, Zaletel K, Dreger T, et al
    A novel, self-shielded modular radiosynthesis system for fully automated preparation of PET and therapeutic radiopharmaceuticals.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  127. OZMEN O, Koyuncu A, Koksal D, Tatci E, et al
    The potential value of volume-based quantitative PET parameters and increased bone marrow uptake for the prediction of survival in patients with malignant pleural mesothelioma.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  128. SCHMITT RJ, Kreidler SM, Glueck DH, Amaria RN, et al
    Correlation between early 18F-FDG PET/CT response to BRAF and MEK inhibition and survival in patients with BRAF-mutant metastatic melanoma.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  129. WIJSMAN R, Grootjans W, Troost EG, van der Heijden EH, et al
    Evaluating the use of optimally respiratory gated 18F-FDG-PET in target volume delineation and its influence on radiation doses to the organs at risk in non-small-cell lung cancer patients.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  130. STRIGARI L, Attili A, Duggento A, Chiaravalloti A, et al
    Quantitative analysis of basal and interim PET/CT images for predicting tumor recurrence in patients with Hodgkin's lymphoma.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  131. JAIMINI A, D'Souza MM, Seniaray N, Sharma H, et al
    Characterization of 'cold' vertebrae on 18F-FDG PET/CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  132. MIWA K, Umeda T, Murata T, Wagatsuma K, et al
    Evaluation of scatter limitation correction: a new method of correcting photopenic artifacts caused by patient motion during whole-body PET/CT imaging.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  133. AGARWAL KK, Mukherjee A, Sharma P, Bal C, et al
    Incremental value of 99mTc-MDP hybrid SPECT/CT over planar scintigraphy and SPECT in avascular necrosis of the femoral head.
    Nucl Med Commun. 2015;36:1055-1062.
    PubMed     Text format     Abstract available


    September 2015
  134. PANDEY AK, Kumar JP, Aheer D, Sharma A, et al
    Development of a conversion program to make SIMIND-generated SPECT data interfile acceptable to Xeleris.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  135. LIU H, Chen P, Wroblewski K, Hou P, et al
    Consistency of metabolic tumor volume of non-small-cell lung cancer primary tumor measured using 18F-FDG PET/CT at two different tracer uptake times.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  136. PEREIRA AM, Husmann L, Sah BR, Battegay E, et al
    Determinants of diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  137. SIMSEK FS, Ispiroglu M, Tasdemir B, Koroglu R, et al
    What approach should we take for the incidental finding of increased 18F-FDG uptake foci in the colon on PET/CT?
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  138. SAMARIN A, Hullner M, Queiroz MA, Stolzmann P, et al
    18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  139. OKADA M, Kikuchi T, Okamura T, Ikoma Y, et al
    In-vivo imaging of blood-brain barrier permeability using positron emission tomography with 2-amino-[3-11C]isobutyric acid.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  140. SIMONCIC U, Perlman S, Liu G, Jeraj R, et al
    Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  141. THEODORAKIS L, Loudos G, Prassopoulos V, Kappas C, et al
    Prospective PET image quality gain calculation method by optimizing detector parameters.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  142. HAN EJ, Yang YJ, Park JC, Park SY, et al
    Prognostic value of early response assessment using 18F-FDG PET/CT in chemotherapy-treated patients with non-small-cell lung cancer.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  143. MA C, Li D, Yin Y, Cao J, et al
    Comparison of characteristics of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET during staging of esophageal squamous cell carcinoma.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  144. O'DOHERTY J, Chilcott A, Dunn J
    Effect of tubing length on the dispersion correction of an arterially sampled input function for kinetic modeling in PET.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  145. MALIK D
    Drug-augmented hepatobiliary scintigraphy for evaluation of neonatal cholestasis: What does the evidence point to?
    Nucl Med Commun. 2015;36:966.
    PubMed     Text format    


  146. SADEGHI R
    Drug augmented hepatobiliary scintigraphy for evaluation of neonatal cholestasis: what does the evidence point to?
    Nucl Med Commun. 2015;36:965.
    PubMed     Text format    


    August 2015
  147. KURISU S, Iwasaki T, Abe N, Tamura M, et al
    Effects of myocardial perfusion abnormalities on the accuracy of left ventricular volume and ejection fraction measured by thallium-201 gated single-photon emission tomography: comparison with echocardiography as the reference standard.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  148. DANILENKO A, Charest M, Leblond A
    The relative value of 18F-FDG PET interpretation criteria in generating a probabilistic approach for characterization of pulmonary nodules.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  149. O'SHAUGHNESSY E, Dixon KL
    Reducing CT dose in myocardial perfusion SPECT/CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  150. HJORTHAUG K, Hojbjerg JA, Knap MM, Tietze A, et al
    Accuracy of 18F-FDG PET-CT in triaging lung cancer patients with suspected brain metastases for MRI.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  151. NOCUN A, Chrapko B
    Multiple and solitary skeletal muscle metastases on 18F-FDG PET/CT imaging.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available



  152. News and Views.
    Nucl Med Commun. 2015;36:863-6.
    PubMed     Text format    


  153. LIU M, Fu Z, Li Q, Di L, et al
    Delayed renal tissue tracer transit in Tc-99m-DTPA renography correlates with postoperative renal function improvement in UPJO patients.
    Nucl Med Commun. 2015;36:833-8.
    PubMed     Text format     Abstract available


  154. TAMAM C, Tamam MO, Yildirim D, Mulazimoglu M, et al
    Diagnostic value of single-photon emission computed tomography combined with computed tomography in relation to MRI on osteochondral lesions of the talus.
    Nucl Med Commun. 2015;36:808-14.
    PubMed     Text format     Abstract available


  155. MALIK D, Khan SH, Ali SW, Rather TA, et al
    Comparison of phenobarbitone and ursodeoxycholic acid in drug-augmented hepatobiliary scintigraphy for excluding the diagnosis of obstructive cholestasis in neonatal cholestasis syndrome.
    Nucl Med Commun. 2015;36:827-32.
    PubMed     Text format     Abstract available


  156. OBARA P, Liu H, Wroblewski K, Zhang CP, et al
    Quantification of metabolic tumor activity and burden in patients with non-small-cell lung cancer: Is manual adjustment of semiautomatic gradient-based measurements necessary?
    Nucl Med Commun. 2015;36:782-9.
    PubMed     Text format     Abstract available


    July 2015
  157. HEINZEL A, Mohammadkhani Shali S, Dafotakis M, Verburg FA, et al
    Comparison of automatic versus manual procedures for the quantification of dopamine D2 receptor availability using I-123-IBZM-SPECT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  158. PEELUKHANA SV, Banerjee R, Kolli KK, Fernandez-Ulloa M, et al
    Benefit of ECG-gated rest and stress N-13 cardiac PET imaging for quantification of LVEF in ischemic patients.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  159. LEE EY, Gill H, Wang Y, Kwong YL, et al
    Bone marrow uptake of indolent non-Hodgkin lymphoma on PET/CT with histopathological correlation.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  160. KWEE TC, Basu S, Alavi A
    Should the nuclear medicine community continue to underestimate the potential of 18F-FDG-PET/CT with present generation scanners for the diagnosis of prosthetic joint infection?
    Nucl Med Commun. 2015;36:756-757.
    PubMed     Text format    


  161. ZARIFMAHMOUDI L, Sadeghi R
    Scattered gamma rays: can they be useful for lymphoscintigraphy imaging?
    Nucl Med Commun. 2015;36:755-6.
    PubMed     Text format    


  162. CROASDALE J
    News and views--July 2015.
    Nucl Med Commun. 2015;36:758-9.
    PubMed     Text format    


  163. WEBB RL, Landau E, Klein D, DiPoce J, et al
    Effects of varying serum glucose levels on 18F-FDG biodistribution.
    Nucl Med Commun. 2015;36:717-21.
    PubMed     Text format     Abstract available


    June 2015
  164. SONG IU, Yoo I, Chung YA, Jeong J, et al
    The value of brain perfusion SPECT for differentiation between mildly symptomatic idiopathic Parkinson's disease and the Parkinson variant of multiple system atrophy.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  165. ARCAN P, Okudan Tekin B, Sefizade R, Naldoken S, et al
    The role of bone SPECT/CT in the evaluation of painful joint prostheses.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  166. RANADE R, Kand P, Basu S
    Value of 18F-FDG PET negativity and Tg suppressibility as markers of prognosis in patients with elevated Tg and 131I-negative differentiated thyroid carcinoma (TENIS syndrome).
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  167. LE ROUX PY, Robin P, Delluc A, Abgral R, et al
    Additional value of combining low-dose computed tomography to V/Q SPECT on a hybrid SPECT-CT camera for pulmonary embolism diagnosis.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  168. DHULL VS, Sharma P, Patel C, Kundu P, et al
    Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available



  169. News and views - June 2015.
    Nucl Med Commun. 2015;36:655-6.
    PubMed     Text format    


  170. KITAMURA H, Kono Y, Murano T, Hiroi K, et al
    Estimation of radioactivity in single-photon emission computed tomography for sentinel lymph node biopsy in a torso phantom study.
    Nucl Med Commun. 2015;36:646-50.
    PubMed     Text format     Abstract available


  171. NOZAWA A, Rivandi AH, Kanematsu M, Hoshi H, et al
    Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes.
    Nucl Med Commun. 2015;36:573-81.
    PubMed     Text format     Abstract available


    May 2015
  172. ASHTON CE, Doyle SC, Redman S, Graham R, et al
    Local validation of the use of Evolution for Bone for bone SPECT imaging.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  173. SARIKAYA I
    Cardiac applications of PET.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  174. NOVIKOV SN, Kanaev SV, Petr KV, Tatyana SY, et al
    Technetium-99m methoxyisobutylisonitrile scintimammography for monitoring and early prediction of breast cancer response to neoadjuvant chemotherapy.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  175. SPIROU SV, Papadimitroulas P, Liakou P, Georgoulias P, et al
    Investigation of attenuation correction in SPECT using textural features, Monte Carlo simulations, and computational anthropomorphic models.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  176. CHENG Z, Wei R, Wu C, Qing H, et al
    Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  177. LOGIURATO B, Matthews R, Safaie E, Moore W, et al
    18F-FDG PET-CT: predicting recurrence in patients following percutaneous cryoablation treatment for stage I primary non-small-cell lung cancer.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  178. KOC M, Kaya GC, Demir Y, Surucu E, et al
    The value of liver-based standardized uptake value and other quantitative 18F-FDG PET-CT parameters in neoadjuvant therapy response in patients with locally advanced rectal cancer: correlation with histopathology.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  179. YONEYAMA H, Tsushima H, Onoguchi M, Konishi T, et al
    Elimination of scattered gamma rays from injection sites using upper offset energy windows in sentinel lymph node scintigraphy.
    Nucl Med Commun. 2015;36:438-44.
    PubMed     Text format     Abstract available


  180. DE MAN KE, Troch ME, Dobbeleir AA, Duong HP, et al
    Comparison of the EANM and SNM guidelines on diuretic renography in children.
    Nucl Med Commun. 2015;36:486-8.
    PubMed     Text format     Abstract available


  181. LI C, Wen B, Wang L, Feng H, et al
    (9)(9)mTc-labeled single-domain antibody EG2 in targeting epidermal growth factor receptor: an in-vitro and mouse model in-vivo study.
    Nucl Med Commun. 2015;36:452-60.
    PubMed     Text format     Abstract available


    April 2015
  182. YUE B, Tang T
    The use of nuclear imaging for the diagnosis of periprosthetic infection after knee and hip arthroplasties.
    Nucl Med Commun. 2015;36:305-11.
    PubMed     Text format     Abstract available


  183. MAFFIONE AM, Paolini R, Rodella E, Ambrosio C, et al
    Response criteria for malignant lymphoma.
    Nucl Med Commun. 2015;36:398-405.
    PubMed     Text format     Abstract available


  184. DEMIRELLI S, Erkilic M, Oner AO, Budak ES, et al
    Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres.
    Nucl Med Commun. 2015;36:340-9.
    PubMed     Text format     Abstract available


    March 2015

  185. News and views March 2015.
    Nucl Med Commun. 2015;36:301-3.
    PubMed     Text format    


  186. VERSCHURE DO, de Wit TC, Bongers V, Hagen PJ, et al
    (1)(2)(3)I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity.
    Nucl Med Commun. 2015;36:279-85.
    PubMed     Text format     Abstract available


  187. SAYMAN HB, Kanmaz B, Uslu I, Al-Nahhas A, et al
    Utility of left lateral supine position for myocardial perfusion single-photon emission computed tomography compared with other methods of correcting inferior wall attenuation.
    Nucl Med Commun. 2015;36:268-78.
    PubMed     Text format     Abstract available


    February 2015
  188. PEIX A, Cabrera LO, Rodriguez L, Padron K, et al
    Cardiac outcomes 3 years after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: value of myocardial perfusion imaging and coronary calcium score.
    Nucl Med Commun. 2015;36:156-61.
    PubMed     Text format     Abstract available


  189. ZHANG L, Liang ML, Zhang YK, Hu SS, et al
    The effects of hypotonic and isotonic negative contrast agent on gastrointestinal distention and physiological intake of 18F-FDG.
    Nucl Med Commun. 2015;36:180-6.
    PubMed     Text format     Abstract available


  190. MORGAT C, Mazere J, Fernandez P, Buj S, et al
    A phantom-based method to standardize dose-calibrators for new beta+-emitters.
    Nucl Med Commun. 2015;36:201-6.
    PubMed     Text format     Abstract available


  191. FUJITA K, Kasama S, Kurabayashi M
    Serial dual single-photon emission computed tomography of thallium-201 and iodine-123 beta-methyliodophenyl pentadecanoic acid scintigraphy can predict functional recovery of patients with coronary artery disease after coronary artery bypass graft sur
    Nucl Med Commun. 2015;36:148-55.
    PubMed     Text format     Abstract available


  192. SIMONCIC U, Zanotti-Fregonara P
    Image-derived input function with factor analysis and a-priori information.
    Nucl Med Commun. 2015;36:187-93.
    PubMed     Text format     Abstract available


  193. SOYDAL C, Araz M, Ozkan E, Arslantas E, et al
    Assessment of recurrence rates in papillary thyroid microcarcinoma patients with and without histopathological risk factors after radioiodine ablation treatment.
    Nucl Med Commun. 2015;36:109-13.
    PubMed     Text format     Abstract available


  194. GENESTRETI G, Bongiovanni A, Burgio MA, Burgio SL, et al
    111In-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance.
    Nucl Med Commun. 2015;36:135-42.
    PubMed     Text format     Abstract available


    January 2015
  195. KAJARY K, Tokes T, Dank M, Kulka J, et al
    Correlation of the value of 18F-FDG uptake, described by SUVmax, SUVavg, metabolic tumour volume and total lesion glycolysis, to clinicopathological prognostic factors and biological subtypes in breast cancer.
    Nucl Med Commun. 2015;36:28-37.
    PubMed     Text format     Abstract available


  196. BERNER AM, Haroon A, Nowosinska E, Offiah C, et al
    Localization of parathyroid disease with 'sequential multiphase and dual-tracer' technique and comparison with neck ultrasound.
    Nucl Med Commun. 2015;36:45-52.
    PubMed     Text format     Abstract available


  197. KUBO TT, Moraes ER, Secaf M, Troncon LE, et al
    A novel dynamic scintigraphic technique for assessing duodenal contractions during gastric emptying in humans: a feasibility study.
    Nucl Med Commun. 2015;36:95-101.
    PubMed     Text format     Abstract available


  198. BENKIRAN M, Mariano-Goulart D, Bourdon A, Sibille L, et al
    Is computed tomography attenuation correction more efficient than gated single photon emission computed tomography analysis in improving the diagnostic performance of myocardial perfusion imaging in patients with low prevalence of ischemic heart disea
    Nucl Med Commun. 2015;36:69-77.
    PubMed     Text format     Abstract available


  199. JANG HY, Kwon SY, Pyo A, Hur MG, et al
    In-house development of an optimized synthetic module for routine [11C]acetate production.
    Nucl Med Commun. 2015;36:102-6.
    PubMed     Text format     Abstract available


    November 2014

  200. BNMS.
    Nucl Med Commun. 2014;35:1191-2.
    PubMed     Text format    


  201. CHRISTENSEN AN
    Commentary to 'application of calibrated image-derived input function to a clinical protocol'.
    Nucl Med Commun. 2014;35:1189-90.
    PubMed     Text format    


  202. ZANOTTI-FREGONARA P, Lyoo CH, Bar-Hen A, Liow JS, et al
    Application of calibrated image-derived input function to a clinical protocol.
    Nucl Med Commun. 2014;35:1188-9.
    PubMed     Text format    


  203. XI Y, Guo R, Hu J, Zhang M, et al
    18F-fluoro-2-deoxy-D-glucose retention index as a prognostic parameter in patients with pancreatic cancer.
    Nucl Med Commun. 2014;35:1112-8.
    PubMed     Text format     Abstract available


    October 2014
  204. BEGIC A, Opankovic E, Cukic V, Rustempasic M, et al
    Impact of ventilation/perfusion single-photon emission computed tomography on treatment duration of pulmonary embolism.
    Nucl Med Commun. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: